SUPN supernus.com Earnings per share growth this year

Corporate emblem and logo of Supernus Pharmaceuticals (SUPN)

Supernus Pharmaceuticals (SUPN) faces the threat of patent expirations and pressure from generics. High barriers to entry are maintained by strict regulatory oversight and costly research. Demand for neurological drugs remains stable, independent of economic cycles. Annual EPS progress visualizes the earnings per share trend, while 23.70 determines the current value of the metric.

Supernus Pharma (SUPN) Earnings per share growth in current year: for the period 07/04/2022 - 11/17/2026

Analytical breakdowns and data insights for company Supernus Pharmaceuticals (SUPN)

- stock price and consensus target price:
Fundamental valuation:Supernus Pharma (SUPN)
Manufactured products of Supernus Corp

This metric measures the annual growth of net income per share, filtering out market noise and demonstrating the business's actual resilience to external shocks. Analyzing the history of annual net income per share growth allows for an assessment of the effectiveness of Supernus Pharmaceuticals (SUPN) portfolio diversification between the epilepsy and ADHD therapy segments, confirming the company's ability to mitigate the risks of narrow specialization in CNS drugs.

Direct competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|CPRX: Net earnings per share growth this year|Earnings per share increase in current year DNLI (Denali Therapeutics)|HRMY: Earnings growth in current year|BHVN (Biohaven Pharmaceutical) - Earnings per share growth in current year|Earnings per share growth in current year Amylyx|Earnings growth in current year Trevi Corp|Earnings growth in current year PRAX|AVXL (anavex.com) - Earnings per share increase in current year|CeriBell Inc - Net earnings per share growth this year|PRTA (Prothena Corporation plc) - Earnings per share trend in current year|ALEC - Earnings per share growth in current year|ANNX (Annexon Biosciences Inc.) - Earnings per share growth this year|OMER (omeros.com) - Net earnings per share growth this year|Earnings per share growth this year NGNE|Net earnings per share growth this year ACIU|Earnings growth in current year Voyager Pharma|Net earnings per share growth this year NMRA (Neumora Therapeutics, Inc.)|SCLX - Earnings per share growth rate in current year|Earnings per share growth in current year Tevogen Bio TVGN|Alpha Cognition Corp (ACOG) - Earnings per share growth rate in current year|CGTX: Net earnings per share growth this year|Inhibikase Therapeutics, Inc. - Net earnings per one share growth for the current year|SAVA: Earnings growth in current year|Earnings per share growth this year ASRT|COYA (coyatherapeutics.com) - Earnings growth in current year|Vistagen (VTGN) - Expected net earnings per share growth this year|Net earnings per share growth this year OVID (Ovid Rx)|Expected net earnings per share growth this year Acumen Pharmaceuticals, Inc.|Earnings growth in current year CRVO (CervoMed Corporation)|Net earnings per one share growth for the current year ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Earnings growth in current year|Net earnings per share change in current year pepgen.com (PEPG)|JUNS: Earnings growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio Inc) - Earnings growth in current year|Net earnings per share growth this year Grace Therapeutics, Inc. (GRCE)|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE